ENO1通过依赖YAP1的阿拉基酸代谢促进肝癌发生
Linchong Sun1, Caixia Suo2, Tong Zhang3
1Medical Research Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China. sunlc@mail.ustc.edu.cn.
酶1 (ENO1) 通过增强YAP1转化和调节酸代谢来促进癌症. 阿司匹林可能会阻止这种进展,为肝癌患者提供潜在的治疗益处.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 乙醇酶1 (ENO1) 是一种涉及癌症发展的糖解酶.
- 对于ENO1在瘤发生中的作用的确切机制仍然不完全理解.
研究的目的:
- 阐明ENO1对癌症进展作出贡献的分子机制.
- 研究ENO1在调节RNA翻译和代谢途径中的作用.
- 探索针对肝癌中ENO1通路的治疗潜力.
主要方法:
- 研究了ENO1与YAP1信使RNA (mRNA) 的相互作用.
- 分析了ENO1和YAP1.1对阿拉基酸 (AA) 代谢的调节.
- 检查了癌细胞系和临床样本中关键蛋白质 (PLCB1,HPGD) 的表达.
- 评估了阿司匹林对ENO1媒介癌症进展的影响.
主要成果:
- ENO1与YAP1mRNA结合,促进其翻译并导致YAP1水平的增加.
- 通过PLCB1和HPGD,ENO1和YAP1通过PLCB1和HPGD积极调节替代性酸 (AA) 代谢.
- YAP1/PLCB1/HPGD轴的激活导致前列腺素E2 (PGE2) 的积累,推动癌症的进展.
- 阿司匹林治疗抑制了ENO1介导的癌症进展.
- 在临床肝细胞癌样本中观察到异常ENO1/YAP1/PLCB1激活和减少HPGD表达.
结论:
- ENO1作为一种RNA结合蛋白,通过增强YAP1转化和改变AA代谢来促进瘤发生.
- ENO1/YAP1/PLCB1/HPGD轴代表了癌症发展的新途径.
- 阿司匹林显示出与异常ENO1或YAP1表达相关的肝癌的治疗潜力.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
相关概念视频
Mutagenicity and Carcinogenicity
Induced Pluripotent Stem Cells
Somatic...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
The Ras Gene
Ras is a...
